Ruggieri S - Search Results

1

Presymptomatic tests in Huntington's disease and dominant ataxias.

Cannella M, Simonelli M, D'Alessio C, Pierelli F, Ruggieri S, Squitieri F. Cannella M, et al. Among authors: ruggieri s. Neurol Sci. 2001 Feb;22(1):55-6. doi: 10.1007/s100720170044. Neurol Sci. 2001. PMID: 11487199

2

Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis.

Squitieri F, Berardelli A, Nargi E, Castellotti B, Mariotti C, Cannella M, Lavitrano ML, de Grazia U, Gellera C, Ruggieri S. Squitieri F, et al. Among authors: ruggieri s. Clin Genet. 2000 Jul;58(1):50-6. doi: 10.1034/j.1399-0004.2000.580108.x. Clin Genet. 2000. PMID: 10945661

3

Short-term effects of olanzapine in Huntington disease.

Squitieri F, Cannella M, Porcellini A, Brusa L, Simonelli M, Ruggieri S. Squitieri F, et al. Among authors: ruggieri s. Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jan;14(1):69-72. Neuropsychiatry Neuropsychol Behav Neurol. 2001. PMID: 11234911

4

The prolonged cortical silent period in patients with Huntington's disease.

Modugno N, Currà A, Giovannelli M, Priori A, Squitieri F, Ruggieri S, Manfredi M, Berardelli A. Modugno N, et al. Among authors: ruggieri s. Clin Neurophysiol. 2001 Aug;112(8):1470-4. doi: 10.1016/s1388-2457(01)00599-5. Clin Neurophysiol. 2001. PMID: 11459687

5

Optimizing levodopa pharmacokinetics in Parkinson's disease: the role of COMT inhibitor.

Stocchi F, Vacca L, Grassini P, Battaglia G, Onofrj M, Valente M, Ruggieri S. Stocchi F, et al. Among authors: ruggieri s. Neurol Sci. 2003 Oct;24(3):217-8. doi: 10.1007/s10072-003-0138-7. Neurol Sci. 2003. PMID: 14598095 No abstract available.

6

Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items".

Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G, Rizzoli S, Morisky DE, Lessi P, Ceravolo R; REASON study group. Fabbrini G, et al. Neurol Sci. 2013 Nov;34(11):2015-22. doi: 10.1007/s10072-013-1438-1. Epub 2013 Jun 1. Neurol Sci. 2013. PMID: 23728715

7

Scintigraphic, neuroradiological and clinical comparison in two patients with primary sporadic and two with secondary Fahr's disease.

Caranci G, Grillea G, Barbato F, Brunetti A, Tassinari T, Di Ruzza M, Lena F, Gandolfi B, Castellano AE, Bartolo M, Colonnese C, Modugno N, Ruggieri S, Manfredi M. Caranci G, et al. Among authors: ruggieri s. Neurol Sci. 2011 Apr;32(2):337-41. doi: 10.1007/s10072-010-0444-9. Epub 2010 Nov 6. Neurol Sci. 2011. PMID: 21057841

8

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.

Stocchi F, Vacca L, De Pandis MF, Barbato L, Valente M, Ruggieri S. Stocchi F, et al. Among authors: ruggieri s. Neurol Sci. 2001 Feb;22(1):93-4. doi: 10.1007/s100720170062. Neurol Sci. 2001. PMID: 11487217 Clinical Trial.

9

Amphetamines induce ubiquitin-positive inclusions within striatal cells.

Fornai F, Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Soldani P, Pellegrini A, Capobianco L, De Blasi A, Ruggieri S, Paparelli A. Fornai F, et al. Among authors: ruggieri s. Neurol Sci. 2003 Oct;24(3):182-3. doi: 10.1007/s10072-003-0120-4. Neurol Sci. 2003. PMID: 14598077

10

Combination of two different dopamine agonists in the management of Parkinson's disease.

Stocchi F, Berardelli A, Vacca L, Thomas A, De Pandis MF, Modugno N, Valente M, Ruggieri S. Stocchi F, et al. Among authors: ruggieri s. Neurol Sci. 2002 Sep;23 Suppl 2:S115-6. doi: 10.1007/s100720200096. Neurol Sci. 2002. PMID: 12548370 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters